文献速递神经肿瘤

复发胶质瘤再次切除术中术中定位技术的影响:一项系统综述

The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review.
PubMed 文献 · J Neurooncol · 2024-11-18

该系统综述检索并纳入58篇文献、共5311例接受再次切除术的复发胶质瘤(WHO 2-4级)成人患者,评估术中定位技术的应用证据。仅17%(10/58)的研究报告使用唤醒或睡眠术中定位技术,定位技术应用于5%(280/5311)的患者,唤醒开颅用于3%(142/5311)的患者。作者认为定位技术可用于再次切除术,有一些证据表明其有助于改善临床结局,但文献缺乏高质量支持。

要点

  • 58篇文献共5311例复发胶质瘤再次切除术患者,仅17%(10/58)的研究报告使用术中定位技术。
  • 定位技术应用于5%(280/5311)的患者,唤醒开颅用于3%(142/5311)的患者。
  • 作者认为定位技术可用于再次切除术,有一些证据表明其有助于改善临床结局,但文献缺乏高质量支持。

核心结论

  • 定位技术可用于再次切除术,有一些证据表明其有助于改善临床结局,但文献缺乏高质量支持。

研究设计与样本

  • 系统综述,检索并纳入58篇文章,共5311例接受再次切除术的复发胶质瘤(WHO 2-4级)成人患者。

主要发现

  • 文献检索策略识别出6372篇文章,其中125篇进行资格筛选,全文评估后58篇纳入本综述。
  • 58篇文章中17%(10/58)报告在再次切除术中使用唤醒或睡眠术中定位技术。
  • 定位技术应用于全部患者的5%(280/5311),唤醒开颅用于3%(142/5311)的患者。

临床怎么用

  • 作者主张未来研究应确定定位技术在减少并发症和提高切除范围方面的效用,类似其在初次手术中的获益。

局限性

  • 文献中缺乏使用这些技术的高质量支持。
  • 报告定位技术的研究数量少,除发表偏倚外,可能反映其在复发情形中应用有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Previous evidence suggests that glioma re-resection can be effective in improving clinical outcomes. Furthermore, the use of mapping techniques during surgery has proven beneficial for newly diagnosed glioma patients. However, the effects of these mapping techniques during re-resection are not clear. This systematic review aimed to assess the evidence of using these techniques for recurrent glioma patients. METHODS: A systematic search was performed to identify relevant studies. Articles were eligible if they included adult patients with recurrent gliomas (WHO grade 2-4) who underwent re-resection. Study characteristics, application of mapping, and surgical outcome data on survival, patient functioning, and complications were extracted. RESULTS: The literature strategy identified 6372 articles, of which 125 were screened for eligibility. After full-text evaluation, 58 articles were included in this review, comprising 5311 patients with re-resection for glioma. Of these articles, 17% (10/58) reported the use of awake or asleep intraoperative mapping techniques during re-resection. Mapping was applied in 5% (280/5311) of all patients, and awake craniotomy was used in 3% (142/5311) of the patients. CONCLUSION: Mapping techniques can be used during re-resection, with some evidence that it is useful to improve clinical outcomes. However, there is a lack of high-quality support in the literature for using these techniques. The low number of studies reporting mapping techniques may, next to publication bias, reflect limited application in the recurrent setting. We advocate for future studies to determine their utility in reducing morbidity and increasing extent of resection, similar to their benefits in the primary setting.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. van Opijnen MP, Sadigh Y, Dijkstra ME, et al. The impact of intraoperative mapping during re-resection in recurrent gliomas: a systematic review. J Neurooncol. 2024. PMID: 39556284. doi:10.1007/s11060-024-04874-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。